      Ministry of Chemicals and Fertilizers

      Patients to save Rs. 12,447 crores due to Price Fixation of Essential Medicines
      Posted On: 02 JUL 2019 2:42PM by PIB Delhi


    Union Minister for Chemicals and Fertilizers, Shri D.V. Sadananda Gowda, while giving a written reply to a question on check on drug prices in the country, in Lok Sabha today, stated that the National Pharmaceutical Pricing Authority (NPPA) has taken important measures to check the prices of drugs, under the Drugs (Prices Control) Order (DPCO). He further stated that since its inception till May, 2019, 2033 demand notices have been issued to pharmaceutical companies for overcharging.


    The Minister stated that the price fixation measures have resulted in savings to the patients, as tabulated below:

                                                                 
Particulars                                    Saving to consumer
                                                                 
                                                                 
                                               (Rs. in Crores)   
                                                                 
                                                                 
                                                                 
Under NLEM 2011 from May, 2013 to Feb, 2016    2,422             
                                                                 
                                                                 
                                                                 
Under NLEM 2015 from March, 2016 to till date  2,644             
                                                                 
                                                                 
                                                                 
Cardio vascular and Anti-diabetic medicines    350               
                                                                 
                                                                 
                                                                 
Coronary Stents                                4,547             
                                                                 
                                                                 
                                                                 
Knee Implants                                  1,500             
                                                                 
                                                                 
                                                                 
Anti-Cancer Drugs                              984               
                                                                 
                                                                 
                                                                 
TOTAL                                          12,447            
                                                                 
                                                                 

    Further, the measures taken by NPPA to keep drug prices in check are as follows:


    (i) After inclusion of National List of Essential Medicines (NLEM), 2011 in the Schedule-I of DPCO, 2013, NPPA fixed the ceiling prices of 530 scheduled formulations.


    (ii) Schedule-I of DPCO, 2013 was amended by adopting NLEM, 2015. Accordingly, NPPA fixed the ceiling prices of 857 scheduled formulations.


    (iii) The ceiling prices of Coronary Stent were notified in February, 2017 resulting into reduction in price up to 85%.


    (iv) NPPA has fixed the ceiling prices of the Orthopedic Knee Implants in August, 2017 under para 19 of DPCO, 2013, resulting in to reduction in price up to 69%.


    (v) NPPA capped the maximum retail price of 106 formulations (anti-diabetic and cardiovascular) under para 19 of DPCO, 2013 in July, 2014.


    (vi) Further, NPPA capped the prices of 42 non-scheduled anti-cancer medicines under ‘Trade Margin Rationalization’ approach. Accordingly, MRP of 526 brands of these medicines have shown reduction up to 90%.


    *****


    KSP/VM

    
    
    (Release ID: 1576642) Visitor Counter : 920
    
    
      Read this release in: Urdu , Marathi , Malayalam